サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1784825

動物用ステントの世界市場

Veterinary Stents

出版日
ページ情報
英文 235 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
動物用ステントの世界市場
出版日: 2025年08月06日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用ステントの世界市場は2030年までに7,570万米ドルに達する見込み

2024年に5,220万米ドルと推定される動物用ステントの世界市場は、2024年から2030年にかけてCAGR 6.4%で成長し、2030年には7,570万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである気道ステントは、CAGR 7.9%を記録し、分析期間終了時には3,900万米ドルに達すると予測されます。尿道ステントセグメントの成長率は、分析期間中CAGR 4.4%と推定されます。

米国市場は1,370万米ドルと推定、中国はCAGR6.2％で成長予測

米国の動物用ステント市場は2024年に1,370万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.2%として、2030年までに1,210万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.1％と5.3％と予測されています。欧州では、ドイツがCAGR 5.0%で成長すると予測されています。

世界の動物用ステント市場- 主要動向と促進要因のまとめ

なぜ動物用ステントが動物ヘルスケアに不可欠になりつつあるのか？

動物用ステントは、動物の気管虚脱、尿道閉塞、心血管異常、胆道閉塞など、さまざまな症状の治療に欠かせないツールとして登場しました。獣医学が進歩するにつれて、ステント留置は従来の外科的介入に代わる低侵襲の選択肢となり、以前は大がかりでリスクの高い処置が必要であった病態を長期にわたって緩和することができるようになりました。気管虚脱は、特にヨークシャー・テリアやポメラニアンのような小型犬種によく見られるが、ステントは即座に気道を確保し、呼吸を改善するため、ステント採用の大きな原動力となっています。同様に、尿道ステントや胆道ステントは、コンパニオンアニマルや家畜の閉塞性疾患の治療を一変させ、閉塞した通路を長期にわたって開通させることを可能にしました。獣医心臓学もまた、特に肺動脈狭窄症などの先天性心疾患の治療において、ステント留置術の恩恵を受けています。回復に要する時間や処置のリスクを軽減する低侵襲技術が重視されるようになり、動物用ステントは現代の動物医療においてますます重要な役割を果たすようになり、複雑な病状に苦しむ動物たちの生活の質を向上させています。

動物用ステント技術の最新の進歩とは？

動物用ステント市場は著しい技術進歩を遂げ、これらの器具の安全性、耐久性、有効性を向上させています。最も注目すべき技術革新のひとつは、外科的介入を必要とせずに解剖学的構造に適合する自己拡張型ニチノールステントの開発です。このステントは柔軟性に優れているため、移動のリスクを軽減し、硬いステントに伴う合併症を最小限に抑えることができます。生分解性ステントもまた、特に長期のステント留置が必要でないような一時的なインターベンションに有望な選択肢として浮上しています。さらに、炎症や再狭窄を予防する薬剤をゆっくりと放出する薬剤溶出性ステントの進歩により、手技後の転帰が改善されつつあります。特定の動物の解剖学的構造に合わせたカスタムデザインのステントが、特に気管や尿道への適用で人気を集めており、より優れた適合を確保し、不快感を軽減しています。ステント留置のための透視ガイダンスや内視鏡ガイダンスの使用により精度がさらに向上し、獣医師は最小限の侵襲でステントを留置できるようになりました。生体材料と獣医インターベンショナル・ラジオロジーの研究が進化し続けるにつれて、獣医用途におけるステントの有効性と汎用性は大幅に拡大すると予想されます。

動物用ステントの普及を阻む課題とは？

動物用ステントの有効性は証明されていますが、いくつかの課題が動物用ステントの普及を妨げています。主な障壁のひとつは、ステントそのもの、特殊な画像機器、適切な挿入に必要な専門知識など、ステント留置術に関連する高額な費用です。多くの動物病院や診療所では、必要なインターベンショナル・ラジオロジーのインフラが整っていないため、ステント留置術を受けられるのは設備の整った専門センターだけに限られています。さらに、ステントは閉塞状態を即座に緩和してくれるが、ステントの移動、閉塞、組織の成長といった長期的な合併症の懸念が残るため、継続的なモニタリングが必要となり、場合によっては追加の介入が必要となります。動物に使用されるほとんどのステントはヒトのステントを適応したものであり、必ずしも理想的な解剖学的適合を提供するとは限らないため、動物用ステントのサイズが標準化されていないことも課題です。ステント留置と術後管理を確実に成功させるためには専門的なトレーニングが必要であるため、ステント留置術に伴う学習曲線も採用に制限を与えています。このような課題に対処するには、獣医療に特化したステント設計のさらなる調査、獣医師のトレーニング機会の増加、動物病院におけるインターベンショナル・ラジオロジー・サービスの幅広い利用が必要です。

動物用ステント市場の主な成長促進要因は何か？

動物用ステント市場の成長は、インターベンショナル動物医療の進歩、ペット飼育の増加、低侵襲治療オプションに対する需要の高まりなど、いくつかの要因によってもたらされます。動物に高度な医療を求める飼い主が増える中、回復期間の短縮と治療成績の向上を実現する非外科的ソリューションへの関心が高まっています。獣医循環器学および呼吸器学の分野が拡大していることが、特に先天性疾患や加齢関連疾患の治療用として、気管および血管ステントの需要に大きく寄与しています。さらに、伴侶動物と家畜の両方で尿路疾患と閉塞の有病率が上昇していることが、尿道ステントと胆道ステントの必要性に拍車をかけています。画像処理とステント材料における技術革新もまた、これらの処置をより安全で効果的なものにし、市場の採用をさらに促進しています。インターベンショナル・ラジオロジー設備を備えた動物専門病院の増加により、ステント留置がより身近なものとなり、幅広い患者に対する治療の選択肢が広がっています。獣医療がより侵襲が少なく患者に優しい治療法へとシフトし続ける中、ステントの設計と手技の継続的な改善により長期的な成功率が向上するため、動物用ステント市場は大幅な成長が見込まれています。

セグメント

製品タイプ（気道ステント、尿道ステント、血管ステント、その他ステント）、動物タイプ（犬、猫、その他）、素材（ニチノール、生分解性ポリマー）、用途（気道閉塞、尿路閉塞、血管閉塞、その他用途）、最終用途（動物病院＆クリニック、その他）

調査対象企業の例

  • AccuPath Group Co., Ltd.
  • AbtVet（Stening Group）
  • Alibaba Group Holding Ltd.
  • Arthrex Vet Systems
  • Create Medic Co., Ltd.
  • Dextronix Animal Health
  • Infiniti Medical
  • M.I. Tech Co., Ltd.
  • NuMED For Children
  • TaeWoong Medical USA（VetSarang）
  • UltraVet Medical Devices LLC
  • VCA Animal Hospitals
  • VetMedUSA
  • VetStent
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33271

Global Veterinary Stents Market to Reach US$75.7 Million by 2030

The global market for Veterinary Stents estimated at US$52.2 Million in the year 2024, is expected to reach US$75.7 Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Airway Stents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$39.0 Million by the end of the analysis period. Growth in the Urethral Stents segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Million While China is Forecast to Grow at 6.2% CAGR

The Veterinary Stents market in the U.S. is estimated at US$13.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.1 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Veterinary Stents Market - Key Trends & Drivers Summarized

Why Are Veterinary Stents Becoming Essential in Animal Healthcare?

Veterinary stents have emerged as a vital tool in treating a wide range of conditions, including tracheal collapse, urethral obstruction, cardiovascular anomalies, and biliary duct obstructions in animals. As veterinary medicine advances, stent placement has become a minimally invasive alternative to traditional surgical interventions, providing long-term relief for conditions that previously required extensive and high-risk procedures. Tracheal collapse, particularly common in small dog breeds such as Yorkshire Terriers and Pomeranians, has been a significant driver for the adoption of stents, as they provide immediate airway support and improve breathing. Similarly, urethral and biliary stents have transformed the treatment of obstructive diseases in both companion animals and livestock, allowing for prolonged patency of blocked passages. Veterinary cardiology has also benefited from stenting procedures, particularly in treating congenital heart defects such as pulmonic stenosis. With the growing emphasis on minimally invasive techniques that reduce recovery times and procedural risks, veterinary stents are playing an increasingly important role in modern animal healthcare, offering improved quality of life for animals suffering from complex medical conditions.

What Are the Latest Advancements in Veterinary Stent Technology?

The veterinary stents market has seen significant technological advancements, enhancing the safety, durability, and efficacy of these devices. One of the most notable innovations is the development of self-expanding nitinol stents, which conform to anatomical structures without requiring surgical intervention. These stents provide superior flexibility, reducing the risk of migration and minimizing complications associated with rigid stents. Biodegradable stents are also emerging as a promising alternative, particularly for temporary interventions where long-term stenting may not be necessary. Additionally, advancements in drug-eluting stents, which slowly release medication to prevent inflammation and restenosis, are improving post-procedural outcomes. Custom-designed stents tailored to specific animal anatomies are gaining traction, particularly for tracheal and urethral applications, ensuring a better fit and reducing discomfort. The use of fluoroscopic and endoscopic guidance for stent placement has further improved precision, allowing veterinarians to position stents with minimal invasiveness. As research in biomaterials and veterinary interventional radiology continues to evolve, the effectiveness and versatility of stents in veterinary applications are expected to expand significantly.

What Challenges Are Hindering the Widespread Adoption of Veterinary Stents?

Despite their proven efficacy, several challenges are limiting the widespread adoption of veterinary stents. One of the primary barriers is the high cost associated with stent placement procedures, including the stent itself, specialized imaging equipment, and the expertise required for proper insertion. Many veterinary clinics and hospitals lack the necessary interventional radiology infrastructure, restricting access to stenting procedures to only well-equipped specialty centers. Additionally, while stents offer immediate relief for obstructive conditions, long-term complications such as stent migration, occlusion, and tissue in-growth remain concerns that require continuous monitoring and, in some cases, additional interventions. Another challenge is the lack of standardized veterinary stent sizes, as most stents used in animals are adaptations of human stents, which may not always provide an ideal anatomical fit. The learning curve associated with stenting procedures also limits adoption, as specialized training is required to ensure successful placement and post-operative management. Addressing these challenges will require further research into veterinary-specific stent designs, increased training opportunities for veterinarians, and broader availability of interventional radiology services in veterinary hospitals.

What Are the Key Growth Drivers of the Veterinary Stents Market?

The growth in the veterinary stents market is driven by several factors, including advancements in interventional veterinary medicine, increasing pet ownership, and the rising demand for minimally invasive treatment options. As more pet owners seek advanced medical care for their animals, there is growing interest in non-surgical solutions that offer shorter recovery times and improved outcomes. The expanding field of veterinary cardiology and pulmonology has significantly contributed to the demand for tracheal and vascular stents, particularly for treating congenital and age-related conditions. Additionally, the rising prevalence of urinary tract diseases and obstructions in both companion animals and livestock has fueled the need for urethral and biliary stents. Technological innovations in imaging and stent materials have also made these procedures safer and more effective, further driving market adoption. The increasing number of veterinary specialty hospitals equipped with interventional radiology facilities is making stent placement more accessible, expanding treatment options for a wider range of patients. As veterinary medicine continues to shift toward less invasive and more patient-friendly treatment methods, the veterinary stents market is expected to experience substantial growth, with continuous improvements in stent design and procedural techniques enhancing long-term success rates.

SCOPE OF STUDY:

The report analyzes the Veterinary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Airway Stents, Urethral Stents, Vascular Stents, Other Stents); Animal Type (Dogs, Cats, Others); Material (Nitinol, Biodegradable Polymer); Application (Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions, Other Applications); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • AccuPath Group Co., Ltd.
  • AbtVet (Stening Group)
  • Alibaba Group Holding Ltd.
  • Arthrex Vet Systems
  • Create Medic Co., Ltd.
  • Dextronix Animal Health
  • Infiniti Medical
  • M.I. Tech Co., Ltd.
  • NuMED For Children
  • TaeWoong Medical USA (VetSarang)
  • UltraVet Medical Devices LLC
  • VCA Animal Hospitals
  • VetMedUSA
  • VetStent
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Veterinary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Interventional Veterinary Procedures Drive Adoption of Minimally Invasive Stenting Solutions
    • Rising Incidence of Tracheal Collapse and Urethral Obstruction Throws the Spotlight On Specialty Stent Applications
    • Integration of Fluoroscopy and Endoscopy with Stenting Enhances Procedural Precision and Expands Use Cases
    • Increasing Pet Longevity Spurs Demand for Long-Term Palliative Solutions Such as Stents
    • Customization Capabilities in Stent Design Expands Addressable Market Opportunity for Specialized Animal Anatomy
    • Technological Innovations in Self-Expanding and Bioabsorbable Stents Propel Product Differentiation
    • Growing Popularity of Specialty Veterinary Hospitals Strengthens Business Case for Advanced Interventional Devices
    • Surge in Companion Animal Surgeries Drives Demand for Post-Operative Support Devices Including Stents
    • Improvements in Stent Material Science Generate Opportunities for Lightweight and Flexible Implant Solutions
    • Veterinary Oncologic Applications Drive Adoption of Stents for Palliative Care in Obstructive Tumors
    • Integration of 3D Printing Technology in Stent Manufacturing Spurs Rapid Prototyping and Personalized Implants
    • Collaborations Between Academic Veterinary Centers and Manufacturers Accelerate Clinical Validation of Novel Stent Designs
    • Expansion of Veterinary Training in Interventional Radiology and Cardiology Drives Procedural Uptake
    • Increase in Feline and Small Dog Urethral Disorders Propels Growth in Miniature and Species-Specific Stent Offerings
    • Regulatory Approvals and Clinical Trials for Veterinary-Specific Stents Strengthen Market Accessibility and Trust
    • Rising Pet Insurance Coverage for Advanced Procedures Encourages Use of Premium Interventional Solutions
    • Market Consolidation and Strategic Acquisitions in Veterinary Devices Expand Distribution of Niche Products like Stents
    • Increased Emphasis on Quality of Life Outcomes in Geriatric Pets Spurs Adoption of Non-Surgical Interventions
    • Surge in Cross-Species Application Research Generates Demand for Flexible, Multi-Species Stenting Platforms
    • Development of Antimicrobial and Drug-Eluting Veterinary Stents Sustains Innovation-Driven Market Growth
    • Veterinary Cardiology and Urology Advancements Propel Usage of Specialized Intraluminal Devices Across Animal Health Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Veterinary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Airway Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Airway Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Urethral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Urethral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Stent Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Stent Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Airway Collapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Airway Collapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urinary Tract Obstructions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Urinary Tract Obstructions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Vascular Obstructions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Vascular Obstructions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Nitinol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Nitinol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biodegradable Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Biodegradable Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • JAPAN
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • CHINA
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • EUROPE
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Veterinary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • FRANCE
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • GERMANY
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • UNITED KINGDOM
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030

IV. COMPETITION